Edition:
United States

Charles River Laboratories International Inc (CRL)

CRL on New York Consolidated

80.54USD
13 Jan 2017
Change (% chg)

$-0.20 (-0.25%)
Prev Close
$80.74
Open
$80.93
Day's High
$81.46
Day's Low
$80.30
Volume
288,957
Avg. Vol
469,914
52-wk High
$89.18
52-wk Low
$65.70

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.14 December 16 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 6 6 6
(2) OUTPERFORM 4 3 3 3
(3) HOLD 9 9 8 8
(4) UNDERPERFORM 0 1 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.30 2.40 2.45 2.45

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 11 440.54 446.70 436.98 365.86
Quarter Ending Jun-17 11 468.32 485.14 454.52 388.72
Year Ending Dec-17 20 1,836.20 1,886.00 1,791.03 1,533.77
Earnings (per share)
Quarter Ending Mar-17 14 1.14 1.23 1.04 1.01
Quarter Ending Jun-17 14 1.31 1.39 1.27 1.21
Year Ending Dec-17 21 5.05 5.27 4.94 4.55
LT Growth Rate (%) 8 12.67 16.17 8.20 9.42

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 434.42 425.72 8.70 2.00
Quarter Ending Jun-16 425.08 434.05 8.98 2.11
Quarter Ending Mar-16 354.91 354.87 0.04 0.01
Quarter Ending Dec-15 349.20 353.85 4.65 1.33
Quarter Ending Sep-15 340.23 349.46 9.23 2.71
Earnings (per share)
Quarter Ending Sep-16 1.13 1.18 0.05 4.12
Quarter Ending Jun-16 1.10 1.20 0.10 8.81
Quarter Ending Mar-16 0.90 0.98 0.08 8.82
Quarter Ending Dec-15 0.94 1.00 0.06 6.39
Quarter Ending Sep-15 0.94 1.03 0.09 9.25

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 440.54 441.03 441.48 442.10 365.86
Quarter Ending Jun-17 468.32 468.86 469.41 470.17 388.72
Year Ending Dec-17 1,836.20 1,838.67 1,842.49 1,845.85 1,533.77
Earnings (per share)
Quarter Ending Mar-17 1.14 1.14 1.14 1.14 1.01
Quarter Ending Jun-17 1.31 1.31 1.31 1.30 1.21
Year Ending Dec-17 5.05 5.05 5.05 5.05 4.55

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 1 0 2
Quarter Ending Jun-17 0 1 0 2
Year Ending Dec-17 0 2 0 5
Earnings
Quarter Ending Mar-17 1 0 2 2
Quarter Ending Jun-17 1 0 2 2
Year Ending Dec-17 1 0 2 3